GIC's reduction from 13.03% to 8.49% is a material passive stake decrease, but the filing remains a routine 13G amendment with no change in investment intent. Monitor for further reductions; if GIC drops below 5%, it would no longer be required to file 13G updates.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $40.71entry
- T+1 · 7d ago +0.49%α +0.86% · $40.91
- T+5 · 18h ago −3.78%α −2.09% · $39.17
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
GIC Private Ltd filed an amended Schedule 13G disclosing a combined 8.49% beneficial ownership stake in Medline Inc. as of November 4, 2026, down from the 13.03% stake reported in the prior filing on October 30, 2026. The reduction reflects a significant decrease in GIC's passive holdings, though the stake remains above 5%.
Key Financial Metrics
Key Facts
- GIC Private Ltd disclosed beneficial ownership of 74,634,102 shares of Medline Class A common stock, representing 8.49% of shares outstanding as of November 4, 2026.
- The prior filing (October 30, 2026) reported a combined 13.03% stake, indicating a reduction of approximately 4.54 percentage points.
- GIC Special Investments Private Limited holds 59,408,506 shares (6.76%) and Hux Investment Pte. Ltd. holds 59,408,506 shares (6.76%), with overlapping beneficial ownership.
- GIC certifies the shares were not acquired to change or influence control of the issuer.
- The filing is based on 878,657,055 shares outstanding per Medline's November 4, 2026 10-Q.
Financial Impact
GIC reduced its reported stake from ~13.03% to 8.49%, a decrease of approximately 4.54 percentage points or about 39.9 million shares (based on the 878.7M share count).
Risk Factors
- Continued selling by GIC could signal reduced conviction or portfolio rebalancing.
- The stake reduction may be perceived as a negative signal by the market, though GIC remains a large holder at 8.49%.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001193125-26-451977 |
| Document: 0001193125-26-451977-index.html | 0001193125-26-451977 |
| Document: 0001193125-26-451977.txt | 0001193125-26-451977 |
Track record
30 reports on MDLN
5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today Press Release Bearish 5/10 Entry $36.40 Now $39.17 −7.61% settles Nov 23
- Nov 16, 2026today S-1 Neutral 4/10 Entry $39.05 Now $39.17 +0.31% settles Nov 23
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Viewing Entry $40.71 to $39.17 Now $39.17 −3.78% ▼ −3.78% −2.09% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $40.35 to $42.16 Now $39.17 −2.92% ▲ +4.49% +5.40% vs SPY
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $34.09 to $40.91 Now $39.17 −14.90% ▼ −20.01% −20.59% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $32.12 to $39.64 Now $39.17 +21.95% ▲ +23.41% +26.12% vs SPY
- Oct 21, 202626d ago 8-K Bearish 6/10 Entry $34.88 to $32.00 Now $39.17 −12.30% ▲ +8.26% +8.96% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers